In vitro study using the liver slices demonstrated that insulin enhances convertion of glucose to lipids (Salans and Reaven 1966) . Perfusion study of the liver also confirmed that insulin promote hepatic triglyceride production (Topping and Mayes 1972) . But such insulin action has not been fully demonstrated in man (Bierman 1972) , because injections of insulin also cause an increase of plasma triglyceride removal, in part enhancing the activity of lipoprotein lipase (Bagdage et al. 1968) .
In lipoatrophic diabetes, impairment of fat storage in the adipose tissue causes characteristic generalized lipodystrophy, hyperlipidemia, and glucose intolerance (Laurence 1946 ). Reduction of post heparin lipase activity (Torikai et al. 1965) , and decrease of removal rate in chylomicron and intrinsic triglyceride were demonstrated in this disorder (Hennes and Sheeve 1959) .
The reduced removal rate of plasma triglyceride observed in lipoatrophic diabetes may be regarded as a suitable condition to study the effects of insulin on hepatic triglyceride production. In this study, oral antidiabetic agents or insulin were used to control hyperglycemia in 3 cases of lipoatrophic diabetes. But the treatment did not lower blood sugar and elevated the levels of plasma trigly cerides.
METHODS AND SUBJECTS
Three subjects of lipoatrophic diabetes, 19, 25 and 34 years old female with total lipodystrophy of congenital type, were studied (Table 1) . Glucose intolerance without ketonuria was demonstrated at the age of 14 to 25 years. Hyperlipidemia, hepatomegaly, and muscular hypertrophy were present in all three cases. They were admitted to the hosptial and placed on an isocaloric diet.
Case 1 received first administration of chlorplopamide, buformin or glybenclamide without effects on blood sugar, and then injection of NPH insulin which was increased gradually from 20 to 90 units per day. Cases 2 and 3 received 250 mg of chlorplopamide for about 1 and 3 months, respectively.
The plasma triglyceride levels were determined after overnight fasting using Fletcher's method (Fletcher 1968 Case 1 was placed on a 1200 kcal diet which could not control the hyerglycemia , and then administered chlorplopamide and glybenclamide followed by insulin injections. But blood sugar was not lowered to normal range by these treat ments. Changes of the plasma triglyceride levels in the course of the treatment are shown in Fig. 1 . The level of plasma triglyceride were increased after administration of chlorplopamide, and returned to normal after stopping it . Readministration of chlorplopamide or glybenclamide with and without buformin caused a gradual increase of the plasma triglyceride levels again . NPH insulin was used in 20 up to 90 units per day. In the course of insulin treatment the plasma triglyceride levels were increased to 458 mg/100 ml, and decreased down to 149 mg/100 ml when the insulin dose was kept constant at 52 units per day for 3 weeks. They were elevated again to 659 mg/100 ml when amounts of insulin injected were increased further to 90 units per day , and decreased to 250 mg/100 ml after keeping the dose constant at 90 units per day . Insulin could not lower the blood sugar level, and the insulin injection was discontinued after 6 months , but di abetic state did not become worse. The plasma triglyceride level decreased to as low as 80 to 190 mg/100 ml after withdrawal of insulin injection .
In Case 2, initiation of chloroplopamide administration gave rise to the eleva tion of the plasma levels of triglyceride from 59 mg/100 ml to 249 mg/100 ml , which were reduced to 150 mg/100 ml on the 19th and 75th days after starting chlorpro pamide administration. Further reduction of the plasma triglyceride levels down to 118 and 98 mg/100 ml was observed after withdrawal of chlorpropamide (Fig.  2a) . 
